Symbol="TAK"
AssetType="Common Stock"
Name="Takeda Pharmaceutical Co Ltd ADR"
Description="Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan."
CIK="1395064"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, JP"
FiscalYearEnd="March"
LatestQuarter="2023-06-30"
MarketCapitalization="47661560000"
EBITDA="1210649936000"
PERatio="21.49"
PEGRatio="0.593"
BookValue="2043.75"
DividendPerShare="0"
DividendYield="0.0432"
EPS="0.71"
RevenuePerShareTTM="1297.67"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0.0285"
ReturnOnEquityTTM="0.0527"
RevenueTTM="4027477918000"
GrossProfitTTM="2441698000000"
DilutedEPSTTM="0.71"
QuarterlyEarningsGrowthYOY="1.068"
QuarterlyRevenueGrowthYOY="0.095"
AnalystTargetPrice="14.06"
TrailingPE="21.49"
ForwardPE="9.73"
PriceToSalesRatioTTM="0.0126"
PriceToBookRatio="0.981"
EVToRevenue="0.0201"
EVToEBITDA="0.0762"
Beta="0.684"
num_52WeekHigh="17.15"
num_52WeekLow="12.28"
num_50DayMovingAverage="15.82"
num_200DayMovingAverage="15.5"
SharesOutstanding="3109060000"
DividendDate="2023-07-10"
ExDividendDate="2022-09-29"
symbol="TAK"
open="14.92"
high="15.26"
low="14.92"
price="15.12"
volume="5161275.00"
latest_trading_day="2023-08-01"
previous_close="15.26"
change="-0.14"
change_percent="-0.9174%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="36"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="64"
Volume_recent_avg="2288215"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="64"
Aroon_momentum_negative="36"
image_negative_thumbnail_id_1="1140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0173.jpeg"
image_negative_thumbnail_id_2="493"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_neutral_thumbnail_id_1="570"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_neutral_thumbnail_id_2="543"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="990"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
